Analytical Data
-
基因名
KIAA1109
- Application
-
别名
KIAA1109; FSA; KIAA1371; Transmembrane protein KIAA1109; Fragile site-associated protein
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q2LD37
-
表达区间
1-191aa
-
氨基酸序列
MQLDFKSIHVQEPQEPSLQDASLKPKVECSVVTEFTDHICVTMDAELIMFLHDLVSAYLKEKEKAIFPPRILSTRPGQKSPIIIHDDNSSDKDREDSITYTTVDWRDFMCNTWHLEPTLRLISWTGRKIDPVGVDYILQKLGFHHARTTIPKWLQRGVMDPLDKVLSVLIKKLGTALQDEKEKKGKDKEEH
-
分子量
48.5 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
KIAA1109, a gene located on chromosome 11, encodes a protein that has garnered significant attention due to its potential involvement in various biological processes and diseases. Initially identified through genomic studies, KIAA1109 has been linked to cellular mechanisms such as cell proliferation, differentiation, and immune response regulation. Recent investigations have revealed that the KIAA1109 protein may play a crucial role in the development and maintenance of certain tissues, as well as in the pathophysiology of disorders including cancer and autoimmune diseases. The focus on recombinant KIAA1109 protein aims to elucidate its functional properties and to explore its interactions within biological pathways. Advances in recombinant DNA technology have enabled the production of this protein in substantial quantities, facilitating in vitro studies. These studies aim to characterize the protein's structure, binding affinities, and enzymatic activities, advancing our understanding of its role in health and disease. Furthermore, uncovering the functional implications of KIAA1109 may pave the way for novel therapeutic strategies, targeting its pathways to treat related diseases. Overall, the investigation of recombinant KIAA1109 protein is vital for comprehending its biological significance and potential as a therapeutic target in medicine.
